221 related articles for article (PubMed ID: 33298762)
1. Impact of Streptococcus salivarius K12 on Nasopharyngeal and Saliva Microbiome: A Randomized Controlled Trial.
Sarlin S; Tejesvi MV; Turunen J; Vänni P; Pokka T; Renko M; Tapiainen T
Pediatr Infect Dis J; 2021 May; 40(5):394-402. PubMed ID: 33298762
[TBL] [Abstract][Full Text] [Related]
2. Multi-Strain Probiotic Supplementation with a Product Containing Human-Native
Cernioglo K; Kalanetra KM; Meier A; Lewis ZT; Underwood MA; Mills DA; Smilowitz JT
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959944
[No Abstract] [Full Text] [Related]
3. Probiotic
Wang Y; Li J; Zhang H; Zheng X; Wang J; Jia X; Peng X; Xie Q; Zou J; Zheng L; Li J; Zhou X; Xu X
Front Immunol; 2021; 12():684824. PubMed ID: 34149727
[TBL] [Abstract][Full Text] [Related]
4. Influence of Oral Probiotic Streptococcus salivarius K12 on Ear and Oral Cavity Health in Humans: Systematic Review.
Zupancic K; Kriksic V; Kovacevic I; Kovacevic D
Probiotics Antimicrob Proteins; 2017 Jun; 9(2):102-110. PubMed ID: 28236205
[TBL] [Abstract][Full Text] [Related]
5. Interferon Gamma Response in Human Saliva Following Exposure to the Oral Probiotic Streptococcus salivarius BLIS K12.
Laws GA; Harold LK; Tagg JR; Hale JDF
Probiotics Antimicrob Proteins; 2024 Feb; 16(1):93-98. PubMed ID: 36477439
[TBL] [Abstract][Full Text] [Related]
6. Streptococcus salivarius Probiotics to Prevent Acute Otitis Media in Children: A Randomized Clinical Trial.
Sarlin S; Koskela U; Honkila M; Tähtinen PA; Pokka T; Renko M; Tapiainen T
JAMA Netw Open; 2023 Nov; 6(11):e2340608. PubMed ID: 37917062
[TBL] [Abstract][Full Text] [Related]
7. Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12.
Power DA; Burton JP; Chilcott CN; Dawes PJ; Tagg JR
Eur J Clin Microbiol Infect Dis; 2008 Dec; 27(12):1261-3. PubMed ID: 18560907
[TBL] [Abstract][Full Text] [Related]
8. Persistence of the oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristics.
Burton JP; Wescombe PA; Macklaim JM; Chai MH; Macdonald K; Hale JD; Tagg J; Reid G; Gloor GB; Cadieux PA
PLoS One; 2013; 8(6):e65991. PubMed ID: 23785463
[TBL] [Abstract][Full Text] [Related]
9. The short-term impact of probiotic consumption on the oral cavity microbiome.
Dassi E; Ferretti P; Covello G; ; Bertorelli R; Denti MA; De Sanctis V; Tett A; Segata N
Sci Rep; 2018 Jul; 8(1):10476. PubMed ID: 29992994
[TBL] [Abstract][Full Text] [Related]
10. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters.
Burton JP; Chilcott CN; Moore CJ; Speiser G; Tagg JR
J Appl Microbiol; 2006 Apr; 100(4):754-64. PubMed ID: 16553730
[TBL] [Abstract][Full Text] [Related]
11. Effect of Oral Probiotic Streptococcus salivarius K12 on Group A Streptococcus Pharyngitis: A Pragmatic Trial in Schools.
Doyle H; Pierse N; Tiatia R; Williamson D; Baker M; Crane J
Pediatr Infect Dis J; 2018 Jul; 37(7):619-623. PubMed ID: 29189607
[TBL] [Abstract][Full Text] [Related]
12. Effect of administration of Streptococcus salivarius K12 on the occurrence of streptococcal pharyngo-tonsillitis, scarlet fever and acute otitis media in 3 years old children.
Di Pierro F; Colombo M; Giuliani MG; Danza ML; Basile I; Bollani T; Conti AM; Zanvit A; Rottoli AS
Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4601-4606. PubMed ID: 27874935
[TBL] [Abstract][Full Text] [Related]
13. A microbiome case-control study of recurrent acute otitis media identified potentially protective bacterial genera.
Lappan R; Imbrogno K; Sikazwe C; Anderson D; Mok D; Coates H; Vijayasekaran S; Bumbak P; Blyth CC; Jamieson SE; Peacock CS
BMC Microbiol; 2018 Feb; 18(1):13. PubMed ID: 29458340
[TBL] [Abstract][Full Text] [Related]
14. Enhanced microbial diversity in the saliva microbiome induced by short-term probiotic intake revealed by 16S rRNA sequencing on the IonTorrent PGM platform.
Dassi E; Ballarini A; Covello G; ; Quattrone A; Jousson O; De Sanctis V; Bertorelli R; Denti MA; Segata N
J Biotechnol; 2014 Nov; 190():30-9. PubMed ID: 24670254
[TBL] [Abstract][Full Text] [Related]
15. Safety assessment of the oral cavity probiotic Streptococcus salivarius K12.
Burton JP; Wescombe PA; Moore CJ; Chilcott CN; Tagg JR
Appl Environ Microbiol; 2006 Apr; 72(4):3050-3. PubMed ID: 16598017
[TBL] [Abstract][Full Text] [Related]
16. Streptococcus salivarius inhibits immune activation by periodontal disease pathogens.
MacDonald KW; Chanyi RM; Macklaim JM; Cadieux PA; Reid G; Burton JP
BMC Oral Health; 2021 May; 21(1):245. PubMed ID: 33962608
[TBL] [Abstract][Full Text] [Related]
17. In vitro Inhibition of Clinical Isolates of Otitis Media Pathogens by the Probiotic Streptococcus salivarius BLIS K12.
Chen TY; Hale JDF; Tagg JR; Jain R; Voss AL; Mills N; Best EJ; Stevenson DS; Bird PA; Walls T
Probiotics Antimicrob Proteins; 2021 Jun; 13(3):734-738. PubMed ID: 33179212
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Oral Probiotics (Streptococcus Salivarius k12) on the Salivary Level of Secretory Immunoglobulin A, Salivation Rate, and Oral Biofilm: A Pilot Randomized Clinical Trial.
Babina K; Salikhova D; Polyakova M; Svitich O; Samoylikov R; Ahmad El-Abed S; Zaytsev A; Novozhilova N
Nutrients; 2022 Mar; 14(5):. PubMed ID: 35268099
[TBL] [Abstract][Full Text] [Related]
19. Human Systemic Immune Response to Ingestion of the Oral Probiotic Streptococcus salivarius BLIS K12.
Laws GL; Hale JDF; Kemp RA
Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1521-1529. PubMed ID: 34282568
[TBL] [Abstract][Full Text] [Related]
20. Use of
Bertuccioli A; Gervasi M; Annibalini G; Binato B; Perroni F; Rocchi MBL; Sisti D; Amatori S
Front Immunol; 2023; 14():1129060. PubMed ID: 36936914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
